Press Releases
| May 2013 | |
 |
Record Sales and Profits Date: April 26Size: 230Kb |
|
Lupin announces Executive Board Leadership Changes
Date: April 17Size: 128Kb |
| April 2013 | |
|
Lupin receives FDA approval for its Oral Contraceptive Pirmella™ 7/7/7 and Pirmella™ 1/35 Tablets
Date: April 26Size: 173Kb |
|
Lupin announces favorable ruling for generic Yaz® Oral Contraceptive Tablets Date: April 17Size: 172Kb |
|
Lupin launches its Oral Contraceptive DayseeTM Tablets in the US Market
Generic of Seasonique® Tablets Date: April 12Size: 141Kb |
 |
Now government hospitals in Maharashtra to use generic drugs Date: April 03 |
| March 2013 | |
|
Lupin Launches Generic Diovan HCT® Tablets Date: March 22Size: 145Kb |
| February 2013 | |
|
Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL Date: February 22Size: 145Kb |
|
Lupin Receives FDA Approval for Lorazepam Oral Concentrate USP, 2 mg/mL Date: February 21Size: 138Kb |
| January 2013 | |
|
Record Sales and Profits -
Quarter III Results, FY 2012‐13 Date: January 31Size: 222Kb |
|
Lupin Receives FDA Approval for Generic Plan B® Tablets, 0.75 mg® Tablets Date: January 24Size: 169Kb |
|
Lupin Receives FDA Approval to Market Generic Lutera® Tablets Date: January 22Size: 169Kb |
